Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Industrials ETF Vanguard | VIS | Nov 26, 2024 | 279.13 | -0.03 |
Infinera | INFN | Nov 26, 2024 | 6.61 | -0.15 |
InflaRx N.V | IFRX | Nov 26, 2024 | 2.20 | +3.77 |
Inflection Point Acquisition II | IPXX | Nov 26, 2024 | 10.78 | +0.89 |
Inflection Point Acquisition II Unit | IPXXU | Nov 26, 2024 | 10.86 | 0.00 |
Infobird | IFBD | Nov 26, 2024 | 1.82 | -5.21 |
Informatica | INFA | Nov 26, 2024 | 26.60 | +0.87 |
Information Services Group | III | Nov 26, 2024 | 3.60 | +0.84 |
Information Technology ETF Vanguard | VGT | Nov 26, 2024 | 623.17 | +0.30 |
Infosys ADR | INFY | Nov 26, 2024 | 23.18 | +1.49 |
InfuSystems | INFU | Nov 26, 2024 | 8.95 | -3.24 |
ING Group ADR | ING | Nov 26, 2024 | 15.10 | -1.56 |
Ingersoll Rand | IR | Nov 26, 2024 | 104.74 | -0.58 |
Ingevity | NGVT | Nov 26, 2024 | 47.51 | -5.38 |
Ingles Markets A | IMKTA | Nov 26, 2024 | 74.20 | -1.46 |
Ingram Micro Holding Corp | INGM | Nov 26, 2024 | 21.82 | 0.00 |
Ingredion | INGR | Nov 26, 2024 | 148.80 | +0.35 |
Inhibikase Therapeutics | IKT | Nov 26, 2024 | 2.36 | +0.85 |
Inhibrx Biosciences | INBX | Nov 26, 2024 | 15.45 | +3.97 |
InMed Pharmaceuticals | INM | Nov 26, 2024 | 4.53 | +0.67 |
InMode | INMD | Nov 26, 2024 | 19.25 | -1.38 |
INmune Bio | INMB | Nov 26, 2024 | 4.88 | +1.67 |
Innate Pharma ADR | IPHA | Nov 26, 2024 | 1.50 | +3.45 |
Inno Holdings | INHD | Nov 26, 2024 | 5.26 | +12.15 |
Innodata | INOD | Nov 26, 2024 | 40.37 | -11.06 |
Innospec | IOSP | Nov 26, 2024 | 117.65 | -1.92 |
InnovAge | INNV | Nov 26, 2024 | 4.77 | +0.42 |
Innovate | VATE | Nov 26, 2024 | 6.13 | +3.55 |
Innovation Beverage Group | IBG | Nov 26, 2024 | 1.22 | 0.00 |
Innovative Eyewear | LUCY | Nov 26, 2024 | 6.88 | +0.29 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.